What is Vivonics?
Vivonics Inc. operates at the intersection of engineering and clinical science, specializing in the development of sophisticated medical technologies designed to optimize human health and performance. The company maintains a robust product pipeline that includes physiological monitoring systems, precision surgical solutions, and next-generation prosthetics. By leveraging non-invasive interventions and advanced diagnostics, Vivonics addresses critical gaps in both military operational health and civilian patient care. Their multidisciplinary team of scientists and engineers collaborates extensively with academic and clinical institutions to ensure that their technological advancements meet rigorous standards for efficacy and reliability in high-stakes environments.
How much funding has Vivonics raised?
Vivonics has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Vivonics
PPP
Public-Private Partnership
What's next for Vivonics?
Following this late-stage financing, Vivonics is positioned to accelerate the commercialization of its core health-monitoring platforms. The strategic deployment of this capital will likely focus on expanding manufacturing capabilities and deepening market penetration within the defense and healthcare sectors. As the company transitions into this next phase of growth, the focus will remain on refining its diagnostic suite and scaling production to meet the increasing demand for mobile, high-performance health solutions. By maintaining its commitment to collaborative research, Vivonics is well-equipped to navigate the complexities of the medical device market while driving long-term value for its stakeholders.
See full Vivonics company page
